The Organisation for Prohibition of Chemical Weapons (OPCW) is reviewing additional information received from Syria about its chemical weapons stockpiles, a United Nations spokesperson has said, ahead of onsite inspections and initial disabling of equipment which could start as early as next week. The OPCW Technical Secretariat, which together with the UN forms the team tasked with overseeing the destruction of Syria’s chemical weapons production facilities, received information that was “additional to the disclosure on its chemical weapons program which Syria submitted on September 21,” UN spokesperson Martin Nesirky told reporters at UN Headquarters in New York on Friday.
Archive for October, 2013
A far-flung group of geeks, supported by the U.S. State Department, has built a tool for anonymous communication that’s so secure that even the world’s most sophisticated electronic spies haven’t figured out how to crack it.
That’s the takeaway from the latest revelations from National Security Agency leaker Edward Snowden. The NSA has used aggressive computer attack techniques to monitor people using the Tor network, a service that’s funded by the U.S. government and allows users to remain anonymous when they’re connected to the Internet. But the agency has not been able to undermine the core of the Tor system, which was developed by the U.S. Naval Research Laboratory in 2002. It remains a viable means for people to connect to the Internet anonymously. Although Tor’s complete reliability has been called into question in light of the NSA’s efforts — which may have begun as early as 2006, according to the Washington Post — for now it’s State Department 1, NSA 0, in the anonymity wars.
Hex is a completely open source nanocopter kit made by a community of makers from around the world. It’s also the world’s first consumer electronic product that uses 3D printing technology to achieve personalization.
Each time we take medicine, we assume that the manufacturer did its best to produce a quality product. Evidence is mounting, however, that some pharmaceutical manufacturers in countries like India cut corners and send low-quality products to major, developed markets. Worse still, they may have separate production lines for drugs they sell in developing markets like Africa, where poor quality is more likely to go unnoticed.
In mid-2013, India’s largest drugmaker, Ranbaxy, pleaded guilty in a U.S. court to several criminal offenses relating to the fraudulent manufacture and sale of adulterated drugs. (The United States is the biggest importer of generic Indian drugs.) Among other revelations, Ranbaxy’s executives acknowledged that “more than 200 products in more than 40 countries” are affected by “elements of data that were fabricated to support [Ranbaxy’s] business needs.” In other words, Ranbaxy made up facts and figures to demonstrate product safety for myriad drugs, including critical HIV medicines paid for by U.S. tax dollars and destined for the poor in Africa. As a consequence, the company was fined $500 million.
Waiting for the tram in the southern Turkish city of Gaziantep, Abu Omar is on his way to the mall. No groceries today, his shopping list includes a Turkish-made tablet computer and a small GPS navigation device loaded with digital maps of the Middle East.
“It’s nothing special,” says Abu Omar, an Iraqi national, as he puts the goods in his rucksack. “But this stuff might come in handy after I make it to Syria.”
Abu Omar, a handsome young man with long black hair, is not the only one making the trek to Syria. Hundreds of Iraqi prisoners, mostly suspected or convicted jihadists, were freed in July after al Qaeda-linked militants staged a deadly jailbreak at the notorious Abu Ghraib prison near Baghdad. At the time, Iraqi and Western authorities feared that some of those men would travel to Syria, helping to fuel the rise of extremist groups there. Those fears have now become a reality.